Abbott-reagent kits (SM)
Ended Awarded Last action
- Contract number
- HHSD2002017F93044
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $87,060
Award facts
- Opportunity
-
- 2017Q66324 Solicitation number
- Contract value 100% obligated
- $87,060.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30329, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of reagent kits, with a ceiling value of $87,060.00. It was awarded under the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III), using a Firm Fixed Price pricing type. The contract has a performance period ending on February 28, 2017. This contract does not have a set-aside designation.
Abbott Molecular is an established provider of molecular diagnostic products and services to federal agencies, including the Department of Veterans Affairs (VA), CDC, and the Department of the Army. The company has been awarded various Indefinite Delivery/Indefinite Quantity (IDIQ) contracts and Blanket Purchase Agreements (BPAs) to supply clinical testing platforms, consumables, and support services to these agencies. Examples include a $12.5 million BPA with VA for Alinity diagnostics reagents, a $6 million BPA with VA for COVID-19 testing capacity, a $7 million IDIQ for Alinity reagents and supplies to VA facilities, and a $2.5 million BPA with the Army Medical Command for HIV-1 genotyping services.
Quick answers
Who was awarded contract HHSD2002017F93044?
HHSD2002017F93044 was awarded to Abbott Molecular Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on February 2, 2017.
How much is contract HHSD2002017F93044 worth?
The government has obligated $87,060 on HHSD2002017F93044.
Is contract HHSD2002017F93044 an order under another contract?
Yes. HHSD2002017F93044 is a delivery order under V797P7323A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract HHSD2002017F93044 competed?
The extent of competition for HHSD2002017F93044 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award